Wednesday, February 1, 2017

BRIEF-Audentes Therapeutics announces FDA clearance of investigational new drug application for AT342

* Audentes Therapeutics announces FDA clearance of

investigational new drug application for AT342 to treat

Crigler-Najjar Syndrome

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)